Concert Pharmaceuticals, Inc. EBITDA 2014-2022 | CNCE
Concert Pharmaceuticals, Inc. ebitda from 2014 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Concert Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2021 | $-76 |
| 2020 | $-71 |
| 2019 | $-78 |
| 2018 | $-56 |
| 2017 | $94 |
| 2016 | $-50 |
| 2015 | $26 |
| 2014 | $-29 |
| 2013 | $-3 |
| 2012 | $-17 |
| 2011 | $-10 |
| Concert Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-09-30 | $-30 |
| 2022-06-30 | $-25 |
| 2022-03-31 | $-36 |
| 2021-12-31 | $-33 |
| 2021-09-30 | $-26 |
| 2021-06-30 | $7 |
| 2021-03-31 | $-24 |
| 2020-12-31 | $-21 |
| 2020-09-30 | $-19 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $-18 |
| 2019-12-31 | $-21 |
| 2019-09-30 | $-18 |
| 2019-06-30 | $-19 |
| 2019-03-31 | $-20 |
| 2018-12-31 | $-20 |
| 2018-09-30 | $-17 |
| 2018-06-30 | $-14 |
| 2018-03-31 | $-4 |
| 2017-12-31 | $-13 |
| 2017-09-30 | $132 |
| 2017-06-30 | $-13 |
| 2017-03-31 | $-13 |
| 2016-12-31 | $-12 |
| 2016-09-30 | $-11 |
| 2016-06-30 | $-13 |
| 2016-03-31 | $-14 |
| 2015-12-31 | $1 |
| 2015-09-30 | $-8 |
| 2015-06-30 | $42 |
| 2015-03-31 | $-9 |
| 2014-12-31 | $-8 |
| 2014-09-30 | $-7 |
| 2014-06-30 | $-7 |
| 2014-03-31 | $-6 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-7 |
| 2013-06-30 | $10 |
| 2013-03-31 | $-1 |
